Skip to main content

ISARIC

Trial Status: Open
R&D Number: BCHCASR126600
Principal Investigator: Dr Joanna Garstang
Date Open to Recruitment: 27 April 2022
Planned Recruitment End Date: 28 March 2023
Sponsors: University of Oxford

International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC). The purpose of this study is to prevent illness and deaths from infectious disease outbreaks. The ISARIC study focuses on the spread and behaviour of COVID-19. More information detailing the ISARIC study can be found here. For CCP-UK Patient Data Notification, please click here.